Pharma & Healthcare
Global Cystic Fibrosis (CF) Therapeutics Market Research Report 2025
- Sep 09, 25
- ID: 498166
- Pages: 89
- Figures: 82
- Views: 4
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis (CF) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis (CF) Therapeutics.
The Cystic Fibrosis (CF) Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cystic Fibrosis (CF) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis (CF) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vertex Pharmaceuticalsorporated
Gilead
AbbVie,
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Segment by Type
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
Segment by Application
Oral drugs
Inhaled drugs
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis (CF) Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cystic Fibrosis (CF) Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cystic Fibrosis (CF) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis (CF) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vertex Pharmaceuticalsorporated
Gilead
AbbVie,
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Segment by Type
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
Segment by Application
Oral drugs
Inhaled drugs
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis (CF) Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pancreatic enzyme supplements
1.2.3 Mucolytics
1.2.4 Bronchodilators
1.2.5 CFTR modulators
1.3 Market by Application
1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral drugs
1.3.3 Inhaled drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis (CF) Therapeutics Market Perspective (2020-2031)
2.2 Global Cystic Fibrosis (CF) Therapeutics Growth Trends by Region
2.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cystic Fibrosis (CF) Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Cystic Fibrosis (CF) Therapeutics Market Dynamics
2.3.1 Cystic Fibrosis (CF) Therapeutics Industry Trends
2.3.2 Cystic Fibrosis (CF) Therapeutics Market Drivers
2.3.3 Cystic Fibrosis (CF) Therapeutics Market Challenges
2.3.4 Cystic Fibrosis (CF) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue
3.1.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
3.4 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio
3.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (CF) Therapeutics Revenue in 2024
3.5 Global Key Players of Cystic Fibrosis (CF) Therapeutics Head office and Area Served
3.6 Global Key Players of Cystic Fibrosis (CF) Therapeutics, Product and Application
3.7 Global Key Players of Cystic Fibrosis (CF) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
4.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2026-2031)
5 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
5.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
6.2 North America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
6.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
7.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
9.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticalsorporated
11.1.1 Vertex Pharmaceuticalsorporated Company Details
11.1.2 Vertex Pharmaceuticalsorporated Business Overview
11.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Introduction
11.1.4 Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.1.5 Vertex Pharmaceuticalsorporated Recent Development
11.2 Gilead
11.2.1 Gilead Company Details
11.2.2 Gilead Business Overview
11.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Introduction
11.2.4 Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.2.5 Gilead Recent Development
11.3 AbbVie,
11.3.1 AbbVie, Company Details
11.3.2 AbbVie, Business Overview
11.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Introduction
11.3.4 AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.3.5 AbbVie, Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Introduction
11.4.4 Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Alaxia
11.6.1 Alaxia Company Details
11.6.2 Alaxia Business Overview
11.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Introduction
11.6.4 Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.6.5 Alaxia Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Details
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Introduction
11.7.4 Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.7.5 Merck & Co. Recent Development
11.8 AIT (Advanced Inhalation Therapies)
11.8.1 AIT (Advanced Inhalation Therapies) Company Details
11.8.2 AIT (Advanced Inhalation Therapies) Business Overview
11.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Introduction
11.8.4 AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.8.5 AIT (Advanced Inhalation Therapies) Recent Development
11.9 ALLERGAN
11.9.1 ALLERGAN Company Details
11.9.2 ALLERGAN Business Overview
11.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Introduction
11.9.4 ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.9.5 ALLERGAN Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Introduction
11.10.4 AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Details
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
11.12 Alcresta
11.12.1 Alcresta Company Details
11.12.2 Alcresta Business Overview
11.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Introduction
11.12.4 Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.12.5 Alcresta Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pancreatic enzyme supplements
1.2.3 Mucolytics
1.2.4 Bronchodilators
1.2.5 CFTR modulators
1.3 Market by Application
1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral drugs
1.3.3 Inhaled drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis (CF) Therapeutics Market Perspective (2020-2031)
2.2 Global Cystic Fibrosis (CF) Therapeutics Growth Trends by Region
2.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cystic Fibrosis (CF) Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Cystic Fibrosis (CF) Therapeutics Market Dynamics
2.3.1 Cystic Fibrosis (CF) Therapeutics Industry Trends
2.3.2 Cystic Fibrosis (CF) Therapeutics Market Drivers
2.3.3 Cystic Fibrosis (CF) Therapeutics Market Challenges
2.3.4 Cystic Fibrosis (CF) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue
3.1.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
3.4 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio
3.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (CF) Therapeutics Revenue in 2024
3.5 Global Key Players of Cystic Fibrosis (CF) Therapeutics Head office and Area Served
3.6 Global Key Players of Cystic Fibrosis (CF) Therapeutics, Product and Application
3.7 Global Key Players of Cystic Fibrosis (CF) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
4.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2026-2031)
5 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
5.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
6.2 North America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
6.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
7.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
9.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticalsorporated
11.1.1 Vertex Pharmaceuticalsorporated Company Details
11.1.2 Vertex Pharmaceuticalsorporated Business Overview
11.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Introduction
11.1.4 Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.1.5 Vertex Pharmaceuticalsorporated Recent Development
11.2 Gilead
11.2.1 Gilead Company Details
11.2.2 Gilead Business Overview
11.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Introduction
11.2.4 Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.2.5 Gilead Recent Development
11.3 AbbVie,
11.3.1 AbbVie, Company Details
11.3.2 AbbVie, Business Overview
11.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Introduction
11.3.4 AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.3.5 AbbVie, Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Introduction
11.4.4 Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Alaxia
11.6.1 Alaxia Company Details
11.6.2 Alaxia Business Overview
11.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Introduction
11.6.4 Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.6.5 Alaxia Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Details
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Introduction
11.7.4 Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.7.5 Merck & Co. Recent Development
11.8 AIT (Advanced Inhalation Therapies)
11.8.1 AIT (Advanced Inhalation Therapies) Company Details
11.8.2 AIT (Advanced Inhalation Therapies) Business Overview
11.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Introduction
11.8.4 AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.8.5 AIT (Advanced Inhalation Therapies) Recent Development
11.9 ALLERGAN
11.9.1 ALLERGAN Company Details
11.9.2 ALLERGAN Business Overview
11.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Introduction
11.9.4 ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.9.5 ALLERGAN Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Introduction
11.10.4 AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Details
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
11.12 Alcresta
11.12.1 Alcresta Company Details
11.12.2 Alcresta Business Overview
11.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Introduction
11.12.4 Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
11.12.5 Alcresta Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pancreatic enzyme supplements
Table 3. Key Players of Mucolytics
Table 4. Key Players of Bronchodilators
Table 5. Key Players of CFTR modulators
Table 6. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2020-2025)
Table 10. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2026-2031)
Table 12. Cystic Fibrosis (CF) Therapeutics Market Trends
Table 13. Cystic Fibrosis (CF) Therapeutics Market Drivers
Table 14. Cystic Fibrosis (CF) Therapeutics Market Challenges
Table 15. Cystic Fibrosis (CF) Therapeutics Market Restraints
Table 16. Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2024)
Table 19. Ranking of Global Top Cystic Fibrosis (CF) Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cystic Fibrosis (CF) Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Cystic Fibrosis (CF) Therapeutics, Product and Application
Table 23. Global Key Players of Cystic Fibrosis (CF) Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Vertex Pharmaceuticalsorporated Company Details
Table 49. Vertex Pharmaceuticalsorporated Business Overview
Table 50. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product
Table 51. Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 52. Vertex Pharmaceuticalsorporated Recent Development
Table 53. Gilead Company Details
Table 54. Gilead Business Overview
Table 55. Gilead Cystic Fibrosis (CF) Therapeutics Product
Table 56. Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 57. Gilead Recent Development
Table 58. AbbVie, Company Details
Table 59. AbbVie, Business Overview
Table 60. AbbVie, Cystic Fibrosis (CF) Therapeutics Product
Table 61. AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 62. AbbVie, Recent Development
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Cystic Fibrosis (CF) Therapeutics Product
Table 66. Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. F. Hoffmann-La Roche Ltd Company Details
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product
Table 71. F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 72. F. Hoffmann-La Roche Ltd Recent Development
Table 73. Alaxia Company Details
Table 74. Alaxia Business Overview
Table 75. Alaxia Cystic Fibrosis (CF) Therapeutics Product
Table 76. Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 77. Alaxia Recent Development
Table 78. Merck & Co. Company Details
Table 79. Merck & Co. Business Overview
Table 80. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product
Table 81. Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Merck & Co. Recent Development
Table 83. AIT (Advanced Inhalation Therapies) Company Details
Table 84. AIT (Advanced Inhalation Therapies) Business Overview
Table 85. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product
Table 86. AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 87. AIT (Advanced Inhalation Therapies) Recent Development
Table 88. ALLERGAN Company Details
Table 89. ALLERGAN Business Overview
Table 90. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product
Table 91. ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 92. ALLERGAN Recent Development
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product
Table 96. AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 97. AstraZeneca Recent Development
Table 98. Teva Pharmaceutical Industries Ltd Company Details
Table 99. Teva Pharmaceutical Industries Ltd Business Overview
Table 100. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product
Table 101. Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 102. Teva Pharmaceutical Industries Ltd Recent Development
Table 103. Alcresta Company Details
Table 104. Alcresta Business Overview
Table 105. Alcresta Cystic Fibrosis (CF) Therapeutics Product
Table 106. Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 107. Alcresta Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Cystic Fibrosis (CF) Therapeutics Picture
Figure 2. Global Cystic Fibrosis (CF) Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Pancreatic enzyme supplements Features
Figure 5. Mucolytics Features
Figure 6. Bronchodilators Features
Figure 7. CFTR modulators Features
Figure 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Oral drugs Case Studies
Figure 11. Inhaled drugs Case Studies
Figure 12. Cystic Fibrosis (CF) Therapeutics Report Years Considered
Figure 13. Global Cystic Fibrosis (CF) Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Cystic Fibrosis (CF) Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2024
Figure 17. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2024
Figure 19. North America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Region (2020-2031)
Figure 33. China Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Vertex Pharmaceuticalsorporated Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 49. Gilead Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 50. AbbVie, Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 51. Novartis AG Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 53. Alaxia Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 54. Merck & Co. Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 55. AIT (Advanced Inhalation Therapies) Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 56. ALLERGAN Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 58. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 59. Alcresta Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pancreatic enzyme supplements
Table 3. Key Players of Mucolytics
Table 4. Key Players of Bronchodilators
Table 5. Key Players of CFTR modulators
Table 6. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2020-2025)
Table 10. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2026-2031)
Table 12. Cystic Fibrosis (CF) Therapeutics Market Trends
Table 13. Cystic Fibrosis (CF) Therapeutics Market Drivers
Table 14. Cystic Fibrosis (CF) Therapeutics Market Challenges
Table 15. Cystic Fibrosis (CF) Therapeutics Market Restraints
Table 16. Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2024)
Table 19. Ranking of Global Top Cystic Fibrosis (CF) Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cystic Fibrosis (CF) Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Cystic Fibrosis (CF) Therapeutics, Product and Application
Table 23. Global Key Players of Cystic Fibrosis (CF) Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Vertex Pharmaceuticalsorporated Company Details
Table 49. Vertex Pharmaceuticalsorporated Business Overview
Table 50. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product
Table 51. Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 52. Vertex Pharmaceuticalsorporated Recent Development
Table 53. Gilead Company Details
Table 54. Gilead Business Overview
Table 55. Gilead Cystic Fibrosis (CF) Therapeutics Product
Table 56. Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 57. Gilead Recent Development
Table 58. AbbVie, Company Details
Table 59. AbbVie, Business Overview
Table 60. AbbVie, Cystic Fibrosis (CF) Therapeutics Product
Table 61. AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 62. AbbVie, Recent Development
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Cystic Fibrosis (CF) Therapeutics Product
Table 66. Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. F. Hoffmann-La Roche Ltd Company Details
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product
Table 71. F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 72. F. Hoffmann-La Roche Ltd Recent Development
Table 73. Alaxia Company Details
Table 74. Alaxia Business Overview
Table 75. Alaxia Cystic Fibrosis (CF) Therapeutics Product
Table 76. Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 77. Alaxia Recent Development
Table 78. Merck & Co. Company Details
Table 79. Merck & Co. Business Overview
Table 80. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product
Table 81. Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Merck & Co. Recent Development
Table 83. AIT (Advanced Inhalation Therapies) Company Details
Table 84. AIT (Advanced Inhalation Therapies) Business Overview
Table 85. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product
Table 86. AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 87. AIT (Advanced Inhalation Therapies) Recent Development
Table 88. ALLERGAN Company Details
Table 89. ALLERGAN Business Overview
Table 90. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product
Table 91. ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 92. ALLERGAN Recent Development
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product
Table 96. AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 97. AstraZeneca Recent Development
Table 98. Teva Pharmaceutical Industries Ltd Company Details
Table 99. Teva Pharmaceutical Industries Ltd Business Overview
Table 100. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product
Table 101. Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 102. Teva Pharmaceutical Industries Ltd Recent Development
Table 103. Alcresta Company Details
Table 104. Alcresta Business Overview
Table 105. Alcresta Cystic Fibrosis (CF) Therapeutics Product
Table 106. Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2020-2025) & (US$ Million)
Table 107. Alcresta Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Cystic Fibrosis (CF) Therapeutics Picture
Figure 2. Global Cystic Fibrosis (CF) Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Pancreatic enzyme supplements Features
Figure 5. Mucolytics Features
Figure 6. Bronchodilators Features
Figure 7. CFTR modulators Features
Figure 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Oral drugs Case Studies
Figure 11. Inhaled drugs Case Studies
Figure 12. Cystic Fibrosis (CF) Therapeutics Report Years Considered
Figure 13. Global Cystic Fibrosis (CF) Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Cystic Fibrosis (CF) Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2024
Figure 17. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2024
Figure 19. North America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Region (2020-2031)
Figure 33. China Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Vertex Pharmaceuticalsorporated Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 49. Gilead Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 50. AbbVie, Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 51. Novartis AG Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 53. Alaxia Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 54. Merck & Co. Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 55. AIT (Advanced Inhalation Therapies) Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 56. ALLERGAN Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 58. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 59. Alcresta Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232